News
Supreme Court Rules Against Makers of Flavored Vapes Popular With Teens
The Supreme Court ruled on Wednesday that the Food and Drug Administration had acted lawfully in rejecting applications from two manufacturers of flavored liquids used in e-cigarettes with names like Jimmy the Juice Man Peachy Strawberry, Signature Series Mom’s Pistachio and Suicide Bunny Mother’s Milk and Cookies.
In a unanimous decision written by Justice Samuel A. Alito Jr., the justices upheld an F.D.A. order that prohibited retailers from marketing flavored tobacco products. The court rejected claims that the agency had unfairly switched its requirements during the application process.
Justice Alito wrote that the agency’s denials of the applications were “sufficiently consistent” with agency guidance on tobacco regulations. The justices rejected a ruling by the U.S. Court of Appeals for the Fifth Circuit that the agency had acted arbitrarily and capriciously, finding that the F.D.A. had not tried to change the rules in the middle of the approval process.
In the opinion, Justice Alito highlighted the possible dangers of the flavored products appealing to middle and high school students, writing that “the kaleidoscope of flavor options adds to the allure of e-cigarettes and has thus contributed to the booming demand for such products among young Americans.”
“Flavors lure kids, which is why Congress gave F.D.A. the authority to make science-based decisions on what is appropriate for our nation’s health,” said Erika Sward, the assistant vice president for nationwide advocacy at the American Lung Association, who applauded the court’s ruling.
The decision comes at a fraught turning point for the agency.
In recent months, leaders celebrated a 10-year low in the percent of adolescents using e-cigarettes. The F.D.A. has attributed the decline to effective messaging targeted at teenagers and to aggressive enforcement against those who market illicit vapes in flavors like Unicorn Shake and watermelon bubble gum.
The agency is also grappling with deep cuts to its tobacco division staff and its counterpart at the Centers for Disease Control and Prevention, which gathers data on youth tobacco use. Amid thousands of staff cuts, Brian King, the director of the F.D.A.’s Center for Tobacco Products, was offered a new role in the Indian Health Service, with the option to work in Alaska or New Mexico — a tacit ouster.
Ms. Sward described the decimation of the federal tobacco control staff as “Christmas Day for big tobacco.”
“There is no one to keep the tobacco industry from flooding the market with its deadly products and no one left to count how many kids they addict,” she said.
The decision on Wednesday is a “ringing validation” of the F.D.A.’s work, said Mitch Zeller, a former director of the agency’s tobacco division who served during the first Trump administration and under Presidents Barack Obama and Joseph R. Biden Jr. But he said its timing — a day after the deep cuts — was ironic and boded poorly for the future of limiting youth tobacco use.
“The Trump administration’s destruction of the Food and Drug Administration and the Center for Tobacco Products, in particular, imperils the ability of the center to continue to do its job on behalf of the public health,” he said.
A 2009 law, the Family Smoking Prevention and Tobacco Control Act, requires makers of new tobacco products to obtain authorization from the F.D.A. According to the law, the manufacturers’ applications must demonstrate that their products are “appropriate for the protection of the public health.”
The agency has denied many applications under the law, including the two at issue in the case before the justices, saying the flavored liquids presented a “known and substantial risk to youth.”
The appeals court ruled last year that the agency had changed the rules in the middle of the application process, accusing it of “regulatory switcheroos” that sent the companies “on a wild-goose chase.” More formally, the court said the agency’s actions had been arbitrary and capricious.
In asking the Supreme Court to hear the case, Food and Drug Administration v. Wages and White Lion Investments, No. 23-1038, the agency’s lawyers cited another appeals court that had reached the opposite conclusion. The Fifth Circuit’s decision “has far-reaching consequences for public health and threatens to undermine the Tobacco Control Act’s central objective of ‘ensuring that another generation of Americans does not become addicted to nicotine and tobacco products,’” they wrote, quoting from the other appeals court’s decision.
What’s next for federal tobacco regulation is uncertain. President Trump has suggested that he will advance the interests of adults who use e-cigarettes, many of whom also use flavored vapes.
Major tobacco companies, though, have complied with F.D.A. rules and gotten approval to sell more staid products, including tobacco and menthol-flavored e-cigarettes. At least one company, Reynolds American, has donated heavily to Mr. Trump’s campaign and has made it clear that it wants the F.D.A. to crack down on the flavored e-cigarettes pouring in from China and taking away its market share.
News
Luigi Mangione’s lawyers withdraw plans for psychiatric defense
Luigi Mangione appears for a pretrial hearing at Manhattan Criminal Court in New York, June 17, 2026.
Angelina Katsanis/AP
hide caption
toggle caption
Angelina Katsanis/AP
New York — In a dramatic reversal, Luigi Mangione’s legal team on Thursday backed away from a plan to use a psychiatric defense when his case goes to trial in state court in September. Mangione has pleaded not guilty to murdering health insurance CEO Brian Thompson in 2024 on a Manhattan street.
At a hearing only a day earlier before state Judge Gregory Carro, Mangione’s attorneys confirmed that Mangione had been undergoing psychiatric evaluation. They signaled that his defense would be based at least in part on the argument that Mangione was experiencing “extreme emotional disturbance.”

But in a one-line letter sent to Carro on Thursday, Mangione’s team said that “at this time” they no longer intend to introduce psychiatric evidence during the trial. It’s unclear what sparked the shift. Mangione’s team didn’t respond to NPR’s request for comment.
Former Manhattan prosecutor and legal analyst Gary Galperin told NPR it was a “stunning reversal” for Mangione to withdraw from the psychiatric defense. “One can only speculate at this point as to the reasons,” he said.
“What remains, of course, at this point is the question of what defense they will pursue at trial,” he added.
This maneuver came after Carro ordered Mangione’s attorneys to quickly share psychiatric information with prosecutors.
“They need to know what the malady is that this defendant suffers and how that triggered extreme emotional distress,” he said, during Wednesday’s hearing. “I’m not going to let you surprise people on the eve of trial. Get it done.”
Assistant Manhattan District Attorney Joel Seidemann repeatedly complained that Mangione’s team was “stonewalling” the prosecution by withholding medical information about his psychiatric state. “We have gotten nothing,” Seidemann said.
Mangione’s lead attorney Karen Friedman Agnifilo denied her team was delaying the court process or improperly withholding information.
But legal analyst Richard Schoenstein says by withdrawing the psychiatric defense, Mangione’s team “is avoiding the court deadline to produce its psychiatric evidence.”
According to Schoenstein, this latest move “does not entirely foreclose” Mangione’s team from returning to some form of psychiatric argument during the trial, but he added that such a defense would now be far more difficult.
Mangione’s case has drawn worldwide attention. Legal experts say the 28-eight-year old has drawn an unusual level of public support because of his criticism of the health insurance industry. Thompson, a father of two, was CEO of UnitedHealthcare at the time of his murder.
During Wednesday’s hearing, Carro also indicated that a tranche of court documents would be made public that apparently relate to Mangione’s potential psychiatric defense. On Thursday, Carro reversed course.
In a signed order, he said that because Mangione will no longer present psychiatric evidence, “the court’s previous order sealing certain transcripts, emails, and documents, remains in effect.”
Mangione’s state trial is scheduled to begin in early September, with a federal trial expected to take place later.
News
Inside Trump’s Touring Exhibition of American Heroes
The museums, designed by conservative nonprofits and Trump appointees, tell the story of early America, from colonization to revolution. The one exhibition looking beyond the early years is the “Wall of American Heroes.” It is a list of 51 people, chosen to illustrate 250 years of American history.
A White House spokesman said they were “individuals who shaped this nation’s history, culture and spirit across generations.”
The people pictured on this national honor roll — and the people left out — help illustrate what this administration sees as the highlights of American history.
Amid the administration’s efforts to reshape the nation’s relationship with its past, Trump appointees heavily weighted the list toward a single era of American history — and a few specific kinds of hero.
The other exhibitions in the Freedom Trucks were crafted by a pair of conservative nonprofits, PragerU and Hillsdale College. But the “Wall of American Heroes” was created by Freedom 250, a nonprofit effort whose leaders were chosen by President Trump and that was created to lead the planning of celebrations of the nation’s 250th birthday, overshadowing a bipartisan congressional commission.
A spokeswoman for Freedom 250 said Mr. Trump was not directly involved in the selection of those featured.
But the list clearly tracks Mr. Trump’s own lifetime and the heroes of the conservative political movement.
The wall’s tilt toward heroes of the baby boomer generation, for instance, extends beyond Hollywood stars and musicians. Of the four religious leaders on the list, two — Archbishop Fulton Sheen and the Rev. Billy Graham — also appeared on TV regularly in the 1950s and 1960s. The only painter on the list is Norman Rockwell, known for his idealized depictions of American life in that period.
By contrast, there is only a handful of figures from the first decades of American independence.
“That’s a disservice, if your intention is to present the last 250 years,” said Sarah Weicksel, the executive director of the American Historical Association. “Because all of the people on this list are building on the work and struggles and progress that was made by the people in the 150 years prior.”
The “Wall of American Heroes” was inspired by a similar display in a traveling museum created by the State of Virginia. But Virginia’s display celebrates little-known historical figures.
Mr. Trump’s, by and large, celebrates people who are already well-known — and, often, people who were famous in their own time. For example, it praises P.T. Barnum, a circus impresario who used hoaxes and freak shows to draw crowds. The wall calls him an “icon of American sensationalism.”
The spokeswoman for Freedom 250 said that many of the names on the wall were drawn from a list of 250 people that Mr. Trump wants to include in a “Garden of American Heroes” in Washington.
The spokeswoman declined to say what criteria were used to narrow down the list.
The only president whose name appears on the wall — not on the list of heroes, but alongside his quotation — is Mr. Trump himself.
Explore the Wall of Heroes
Navigate the display by dragging from side to side.
News
GOP Rep. Tom Kean, missing from Congress for months, set to return on June 30
Washington — Republican Rep. Tom Kean Jr. of New Jersey will return to Congress on June 30, his spokesperson said, after being away since March in an unexplained absence that has confounded Capitol Hill.
“Congressman Kean is eager to return to in person work on June 30 and resume a full schedule,” Kean’s spokesperson, Harrison Neely, told CBS News on Thursday. The New Jersey Globe first reported on his return date.
Kean’s whereabouts since he last voted on March 5 have not been disclosed. When he first made a statement about the absence in late April, the New Jersey Republican said he was addressing a “personal medical issue.”
Kean said earlier this month that he would return to Washington within a matter of weeks, at which point he would provide more details about his health.
“Right now I am focused on my recovery and under the advice of healthcare professionals, I will transition from virtual work to in person work within a matter of weeks. At that time I will be completely transparent as to the nature of my medical condition,” Kean said in a June 2 statement released by his campaign.
The statement came hours before polls closed in New Jersey’s GOP primary for his seat, in which he ran unopposed.
He has missed more than 130 votes during his absence.
House Speaker Mike Johnson told reporters earlier this month that he had recently spoken with Kean. Johnson said he was aware of the health issue, but would not disclose the details.
“What he’s dealing with is not very common and not a big thing,” Johnson said.
-
Health2 minutes agoNew At-Home DNA Test Reveals if GLP-1 Weight-Loss Drugs Will Work for You
-
Lifestyle17 minutes agoWhat does freedom actually look like? : It’s Been a Minute
-
Technology26 minutes agoBarret Zoph is out at OpenAI again after just five months
-
World32 minutes agoIran hardliner behind US deal warns Tehran won’t honor agreement if Trump fails to deliver
-
Politics39 minutes agoTop GOP lawmaker rallies around conservative school board member facing calls to resign
-
Sports47 minutes ago2026 World Cup Odds: How Far Can Mexico Go After Winning Group A?
-
Technology54 minutes ago6 in 10 identity crimes now begin with a new account
-
Business57 minutes agoJanuary 2025 wildfire victims seek tougher penalties against State Farm over claims handling